CompBrief BY VELARION

Companies Mckesson Corp

Mckesson (MCK): executive pay, fiscal 2026

Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me Mckesson Corp’s executive pay brief as a PDF

You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

Also free: The Pay Desk, the weekly executive pay briefing.
CEO total pay$24,213,044CEO Brian Tyler · source
Say-on-pay support91.43%Latest vote · source
CEO vs. named peers70th pct.Of 33 peer CEOs
CEO pay ratio357:1To the median employee · source

CEO pay, last three years

  • $18,997,543FY2024
  • $20,161,714FY2025
  • $24,213,044FY2026

CEO total pay was $24,213,044 in fiscal 2026, up from $20,161,714 in fiscal 2025.

FY2026: salary $1,591,667 · bonus $0 · stock awards $17,201,202 · option awards $0

Executives and directors

Frequently asked questions

Who was the highest-paid executive at Mckesson Corp in fiscal 2026?
As disclosed, Brian Tyler (Chief Executive Officer) was the highest-paid executive at Mckesson Corp in fiscal 2026, with total compensation of $24,213,044.
How does Mckesson Corp's chief executive pay compare to its disclosed peer group?
As disclosed, Brian Tyler's total compensation ranked at the 70th percentile of Mckesson Corp's disclosed peer group.
What is Mckesson Corp's CEO-to-median employee pay ratio?
As disclosed, Mckesson Corp's CEO-to-median employee pay ratio was 357:1.
How did shareholders vote on Mckesson Corp's executive compensation?
As disclosed, 91.43% of shareholders supported Mckesson Corp's executive compensation in the latest say-on-pay vote.
How much does Mckesson Corp spend in total on board compensation for fiscal 2026?
As disclosed, Mckesson Corp reported total board compensation of $4,325,507 for fiscal 2026.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Brian Tyler$1,591,667$0$17,201,202$0$4,456,668$0$963,507$24,213,044
Chief Executive Officer
Britt Vitalone1,064,33305,600,33201,862,5830209,8158,737,063
Executive Vice President and Chief Financial Officer
Michele Lau766,58303,651,38801,073,2160104,8705,596,057
Executive Vice President and Chief Legal Officer
LeAnn Smith693,83302,500,5800971,366087,9304,253,709
Executive Vice President and Chief Human Resources Officer
Thomas Rodgers647,45001,750,6980906,430081,9733,386,551
Executive Vice President and Chief Strategy and Business Development Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2026 totalFY2025 totalFY2024 totalΔ FY2025→2026
Brian Tyler$24,213,044$20,161,714$18,997,543↑ +4,051,330
Britt Vitalone8,737,0637,682,1816,782,661↑ +1,054,882
Michele Lau5,596,0575,226,7058,806,254↑ +369,352
LeAnn Smith4,253,7093,717,8993,541,115↑ +535,810
Thomas Rodgers3,386,5513,213,3073,178,976↑ +173,244

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

McKesson's executive compensation program is predominantly variable and performance-based, designed to align executive interests with long-term shareholder value creation. The program emphasizes a mix of operational and market-based metrics, with a focus on Adjusted EPS, Adjusted Operating Profit, Free Cash Flow, and Relative Total Shareholder Return, while incorporating non-financial priority areas as a downward-only modifier.

CEO STI target (% of salary)200%
CEO LTI target (% of salary)—
Independent consultantKorn Ferry
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2026

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Britt VitaloneRSU2025-05-20——3,115—$2,240,277
Thomas RodgersRSU2025-05-20——974—700,491
Thomas RodgersPSU2025-05-205541,384—3,3221,050,207
Brian TylerRSU2025-05-20——9,567—6,880,491
Michele LauRSU2025-05-20——2,031—1,460,675
Britt VitalonePSU2025-05-201,7714,428—10,6273,360,055
LeAnn SmithPSU2025-05-207911,977—4,7451,500,187
Brian TylerPSU2025-05-205,44013,601—32,64210,320,711
LeAnn SmithRSU2025-05-20——1,391—1,000,393
Michele LauPSU2025-05-201,1552,887—6,9292,190,713

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Britt Vitalone$2,240,277$3,360,055$060.0%
Thomas Rodgers700,4911,050,207060.0%
Brian Tyler6,880,49110,320,711060.0%
Michele Lau1,460,6752,190,713060.0%
LeAnn Smith1,000,3931,500,187060.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2026

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Thomas RodgersRSU2,414—$2,088,979
LeAnn SmithRSU3,133—2,711,173
Michele LauRSU4,238—3,667,396
Britt VitaloneRSU7,005—6,061,847
Thomas RodgersPSU10,512—9,096,664
LeAnn SmithPSU13,368—11,568,132
Michele LauPSU17,511—15,153,319
Brian TylerRSU21,146—18,298,903
Britt VitalonePSU29,818—25,803,304
Brian TylerPSU90,115—77,981,916
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Donald R. KnaussIndependent · Board Chair · Compensation and Talent (Chair) · Not standing for re-election$260,000$335,297$0—$0$595,297
Dominic J. CarusoIndependent · Lead Independent Director · Compensation and Talent · Governance and Sustainability · Audit (Chair)145,000215,1910—0360,191
Kevin M. OzanIndependent · Audit (Chair)140,000215,1910—0355,191
Bradley E. LermanIndependent · Compensation and Talent (Chair)140,000215,1910—0355,191
Maria N. MartinezIndependent · Finance140,000215,1910—0355,191
Lynne M. DoughtieIndependent · Audit · Finance · Newly elected139,000215,1910—0354,191
Julie L. Gerberding, M.D., M.P.HIndependent · Compensation and Talent · Newly elected139,000215,1910—0354,191
James H. HintonIndependent · Audit120,000215,1910—0335,191
W. Roy DunbarIndependent · Compliance (Chair) · Governance and Sustainability120,000215,1910—0335,191
Deborah Dunsire, M.DIndependent · Audit · Finance120,000215,1910—0335,191
Kathleen Wilson-ThompsonIndependent · Compensation and Talent120,000215,1910—0335,191
Richard H. Carmona, M.DIndependent · Not standing for re-election · Departed during FY40,109215,1910—0255,300

Board fee structure and ownership guideline

Annual cash retainer$115,000
Annual equity retainer$200,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 20,000 / 20,000
Stock ownership guideline6x annual cash retainer ($690,000)

Total cost of the board

ComponentFY2026
Cash retainers and fees$1,623,109
Equity awards (grant-date value)$2,702,398
All other compensation$0
Total cost of the board$4,325,507

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Mckesson as a peer

Companies that benchmark against MCK

12 companies name MCK as a compensation peer

The list of companies that name MCK as a peer is temporarily unavailable — recheck shortly.

Disclosed peer group — fiscal year 2026

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

Peer reciprocity

The companies Mckesson Corp names as compensation peers that name it back in their own disclosed peer groups.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1UnitedHealth Group2025Stephen Hemsley$596,154$0$60,000,024$0$60,938,062
2Johnson & Johnson2025Joaquin Duato1,600,00015,028,9485,927,9954,298,70032,758,111
3Walmart2026Doug McMillon1,500,00021,051,60504,032,00029,240,930
4Pfizer2025Albert Bourla1,800,0009,442,7058,998,1415,400,00027,585,301
5FedEx2026Rajesh Subramaniam1,550,0006,731,3643,715,06210,593,50027,554,018
6HCA Healthcare2025Samuel Hazen1,577,8158,474,5438,514,0905,416,73226,456,606
7Mckesson Corp2026Brian Tyler1,591,66717,201,20204,456,66824,213,044
8Abbott Laboratories2025Robert Ford1,500,0008,787,3788,788,4301,968,75024,198,660
9United Parcel Service2025Carol Tomé1,509,71317,550,5461,358,7542,264,56922,878,788
10The Cigna Group2025David Cordani1,600,00013,929,1613,400,0193,200,00022,866,134
11Elevance Health2025Gail Boudreaux1,600,00013,440,2774,199,7652,768,00022,582,314
12Cardinal Health2026Jason Hollar1,500,00016,259,91804,278,75022,574,349
13CVS Health2025J. David Joyner1,500,00014,499,93104,695,90021,214,084
14Merck & Co.2025Robert Davis1,645,30212,102,8383,380,0042,326,50020,797,845
15Procter & Gamble2026Shailesh Jejurikar1,387,50011,035,2093,500,010018,976,742
16Humana2025James Rechtin1,348,55813,868,14103,034,74018,757,075
17Cencora2025Robert Mauch1,350,00012,000,21804,283,21318,256,227
18Sysco2026Kevin Hourican1,435,53810,391,7592,579,9862,905,60217,899,369
19Viatris2025Scott Smith1,448,65410,150,01302,973,66015,273,331
20Kroger2025Ronald L. Sargent3,975,80610,000,077——14,037,608
21Costco2025Ron Vachris1,183,27012,036,8000600,00013,932,597
22Accendra Health, Inc. (formerly Owens & Minor, Inc.)2025Edward Pesicka1,150,0009,560,140—345,00011,157,809
23Target2025Michael Fiddelke1,065,3857,853,2530300,8829,598,071
—Sanofi——————not in coverage universe

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Mckesson Corp140%PSU 60 · RSU 40Yes — Total Shareholder Return (TSR) relative to comparator groupKorn Ferry
Abbott Laboratories75.0%Options 50 · PSU 50NoMeridian Compensation Partners, LLC
Accendra Health, Inc. (formerly Owens & Minor, Inc.)20%RSU 50 · PSU 50not disclosedFrederic W. Cook & Co., Inc. (FW Cook)
Cardinal Healthnot disclosedPSU 60 · RSU 40Yes — Relative TSR modifierKorn Ferry
Cencora181.3%PSU 60 · RSU 40Yes — Relative TSRPearl Meyer & Partners
Costco120%RSU 100NoNone used (Committee has authority to engage consultants but did not use any)
CVS Health156.5%PSU 60 · RSU 20 · Options 20Yes — rTSR ModifierKorn Ferry
Elevance Health86.5%PSU 52 · RSU 24 · Options 24NoWillis Towers Watson (WTW)
FedEx112.5%not disclosedYes — Relative TSR (FY24-FY26 LTI Cash Plan)Meridian Compensation Partners, LLC
HCA Healthcare195.78%SAR 50 · PSU 50NoSemler Brossy
Humana112%PSU 60 · RSU 40Yes — Relative TSRFarient Advisors, LLC
Johnson & Johnsonnot disclosednot disclosedYes — Relative TSRSemler Brossy Consulting Group
Kroger93.84%not disclosedYes — Value creation (iTSR)Korn Ferry; Meridian Compensation Partners, LLC
Merck & Co.94%PSU 60 · RSU 20 · Options 20Yes — Relative Total Shareholder Return (R-TSR)FW Cook
Pfizer150%PSU 50 · MSU 50Yes — relative TSR as compared to the NYSE Arca Pharmaceutical Index (DRG Index or DRG)Meridian Compensation Partners, LLC
Procter & Gamblenot disclosedPSU 50 · RSU 25 · Option 25Yes — Relative TSR MultiplierMeridian Compensation Partners, LLC
Sanofinot disclosednot disclosednot disclosednot disclosed
Sysco115.66%PSU 50 · RSU 30 · Option 20NoSemler Brossy
Targetnot disclosedPSU 60 · PBRSU 40NoSemler Brossy
The Cigna Group100%PSU 60 · RSU 20 · Options 20NoPay Governance
United Parcel Service75%PSU 93 · Options 7Yes — Relative Total Shareowner Return (RTSR)FW Cook
UnitedHealth Groupnot disclosedPSU 50 · Options 25 · RSU 25NoPay Governance
Viatris136.72%PSU 65 · RSU 35NoMeridian Compensation Partners, LLC
Walmart112%not disclosedNoFarient Advisors LLC

Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-07-2286,580,7767,732,776387,19991.43%Passed
20252025-07-3091,831,9977,955,440769,77991.32%Passed
20252025-07-3091,831,9977,955,440769,77991.32%Passed
20232023-07-2196,483,47311,840,048236,25188.88%Passed
20222022-07-22104,716,04511,952,227535,69389.76%Passed
20212021-07-23111,683,24412,582,546475,25889.87%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
20262026-07-2291.43%a
20252025-07-3091.32%b
20252025-07-3091.32%c

a. Approved under the standard stated in the filing — “Shares represented by abstentions will have the effect of a vote against this proposal.”.

b. Approved under the standard stated in the filing — “Shares represented by abstentions will have the effect of a vote against this proposal.”.

c. Approved under the standard stated in the filing — “Shares represented by abstentions will have the effect of a vote against this proposal.”.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

CEO pay ratio

Ratio (CEO : median employee)357 : 1
CEO total compensation$24,213,044
Median employee compensation$67,803
Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2026 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Brian TylerDirector2026-06-17D8,463$775$6,559,925CommonForm 4 ↗
Brian TylerDirector2026-07-07D8,4637946,715,898CommonForm 4 ↗
Dividend-equivalent accruals2026-07-22—1,939——7 insiders, 7 accrual rows
Dominic J. CarusoDirector2026-07-22A277814225,489CommonForm 4 ↗
Maria N. MartinezDirector2026-07-22A277814225,489CommonForm 4 ↗
Kathleen Wilson-ThompsonDirector2026-07-22A277814225,489CommonForm 4 ↗
Dividend-equivalent accruals2026-08-07—368——1 insider, 1 accrual row
Bradley E. LermanDirector2026-08-10D301892268,590CommonForm 4 ↗
Napoleon B. Rutledge JRSVP, Controller & CAO2026-09-08D11189198,951CommonForm 4 ↗
Francisco FragaEVP, CIO and CTO2026-10-15D800.49996797,129CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 16 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Brian TylerDirector2026-06-17D8,463$775$6,559,925CommonForm 4 ↗
Brian TylerDirector2026-07-07D8,4637946,715,898CommonForm 4 ↗
Julie L. GerberdingDirector2026-07-22A27700Derivative, Class A CommonForm 4 ↗
Dominic J. CarusoDirector2026-07-22A277814225,489CommonForm 4 ↗
W. Roy DunbarDirector2026-07-22A27700Derivative, Class A CommonForm 4 ↗
Lynne M. DoughtieDirector2026-07-22A27700Derivative, Class A CommonForm 4 ↗
James H. HintonDirector2026-07-22A27700Derivative, Class A CommonForm 4 ↗
Deborah DunsireDirector2026-07-22A27700Derivative, Class A CommonForm 4 ↗
Kevin M. OzanDirector2026-07-22A27700Derivative, Class A CommonForm 4 ↗
Maria N. MartinezDirector2026-07-22A277814225,489CommonForm 4 ↗
Kathleen Wilson-ThompsonDirector2026-07-22A277814225,489CommonForm 4 ↗
Bradley E. LermanDirector2026-07-22A27700Derivative, Class A CommonForm 4 ↗
Ramesh (NMN) SrinivasanEVP and Chief Strategy Officer2026-08-07A36800Derivative, Class A CommonForm 4 ↗
Bradley E. LermanDirector2026-08-10D301892268,590CommonForm 4 ↗
Napoleon B. Rutledge JRSVP, Controller & CAO2026-09-08D11189198,951CommonForm 4 ↗
Francisco FragaEVP, CIO and CTO2026-10-15D800.49996797,129CommonForm 4 ↗
Sources (81 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, Brian Tyler. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 24,213,044. View filing ↗
  • Section 01, Britt Vitalone. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 8,737,063. View filing ↗
  • Section 01, Michele Lau. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 5,596,057. View filing ↗
  • Section 01, LeAnn Smith. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 4,253,709. View filing ↗
  • Section 01, Thomas Rodgers. DEF 14A, filed 2026-06-12. Section “Summary Compensation Table” · page 64. As printed: 3,386,551. View filing ↗
  • Section 03, Britt Vitalone RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 03, Thomas Rodgers RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 03, Thomas Rodgers PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 03, Brian Tyler RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 03, Michele Lau RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 03, Britt Vitalone PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 03, LeAnn Smith PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 03, Brian Tyler PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 03, LeAnn Smith RSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 03, Michele Lau PSU. DEF 14A, filed 2026-06-12. Section “Grants of Plan-Based Awards Table” · grants of plan-based awards table. View filing ↗
  • Section 07, pay ratio. DEF 14A, filed 2026-06-12. Section “CEO Pay Ratio”. As printed: 357 : 1. View filing ↗
  • Section 08, Donald R. Knauss. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 595,297. View filing ↗
  • Section 08, Dominic J. Caruso. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 360,191. View filing ↗
  • Section 08, Kevin M. Ozan. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 355,191. View filing ↗
  • Section 08, Bradley E. Lerman. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 355,191. View filing ↗
  • Section 08, Maria N. Martinez. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 355,191. View filing ↗
  • Section 08, Lynne M. Doughtie. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 354,191. View filing ↗
  • Section 08, Julie L. Gerberding, M.D., M.P.H. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 354,191. View filing ↗
  • Section 08, James H. Hinton. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 335,191. View filing ↗
  • Section 08, W. Roy Dunbar. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 335,191. View filing ↗
  • Section 08, Deborah Dunsire, M.D. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 335,191. View filing ↗
  • Section 08, Kathleen Wilson-Thompson. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 335,191. View filing ↗
  • Section 08, Richard H. Carmona, M.D. DEF 14A, filed 2026-06-12. Section “Director Compensation”. As printed: 255,300. View filing ↗
  • Section 02, Brian Tyler 2026-06-17. Form 4, filed 2026-06-18. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Brian Tyler 2026-07-07. Form 4, filed 2026-07-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Julie L. Gerberding 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Dominic J. Caruso 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, W. Roy Dunbar 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lynne M. Doughtie 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, James H. Hinton 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Deborah Dunsire 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kevin M. Ozan 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Maria N. Martinez 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kathleen Wilson-Thompson 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Bradley E. Lerman 2026-07-22. Form 4, filed 2026-07-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Ramesh (NMN) Srinivasan 2026-08-07. Form 4, filed 2026-08-11. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Bradley E. Lerman 2026-08-10. Form 4, filed 2026-08-11. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Napoleon B. Rutledge JR 2026-09-08. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Francisco Fraga 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 06, 2026 vote. Form 8-K, filed 2026-07-24. Item 5.07 · say-on-pay result. As reported: 91.43% (votes for as printed: 86,580,776). View filing ↗
  • Section 06, 2025 vote. Form 8-K, filed 2025-08-01. Item 5.07 · say-on-pay result. As reported: 91.32% (votes for as printed: 91,831,997). View filing ↗
  • Section 06, 2025 vote. Form 8-K, filed 2025-08-01. Item 5.07 · say-on-pay result. As reported: 91.32% (votes for as printed: 91,831,997). View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
  • Section 09b board cost (computed). Computed. Cash 1,623,109 + equity 2,702,398 + all other 0 = 4,325,507, summed across the director compensation table rows.
  • UnitedHealth Group, Section 10b CEO total. DEF 14A, filed 2026-04-21. CEO total compensation as printed in UnitedHealth Group's own proxy. As printed: 60,938,062. View filing ↗
  • Johnson & Johnson, Section 10b CEO total. DEF 14A, filed 2026-03-11. CEO total compensation as printed in Johnson & Johnson's own proxy. As printed: 32,758,111. View filing ↗
  • Walmart, Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Walmart's own proxy. As printed: 29,240,930. View filing ↗
  • Pfizer, Section 10b CEO total. DEF 14A, filed 2026-03-12. CEO total compensation as printed in Pfizer's own proxy. As printed: 27,585,301. View filing ↗
  • FedEx, Section 10b CEO total. DEF 14A, filed 2026-08-17. CEO total compensation as printed in FedEx's own proxy. As printed: 27,554,018. View filing ↗
  • HCA Healthcare, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in HCA Healthcare's own proxy. As printed: 26,456,606. View filing ↗
  • Mckesson Corp (subject), Section 10b CEO total. DEF 14A, filed 2026-06-12. CEO total compensation as printed in Mckesson Corp's own proxy. As printed: 24,213,044. View filing ↗
  • Abbott Laboratories, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in Abbott Laboratories's own proxy. As printed: 24,198,660. View filing ↗
  • United Parcel Service, Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in United Parcel Service's own proxy. As printed: 22,878,788. View filing ↗
  • The Cigna Group, Section 10b CEO total. DEF 14A, filed 2026-03-13. CEO total compensation as printed in The Cigna Group's own proxy. As printed: 22,866,134. View filing ↗
  • Elevance Health, Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Elevance Health's own proxy. As printed: 22,582,314. View filing ↗
  • Cardinal Health, Section 10b CEO total. DEF 14A, filed 2026-09-21. CEO total compensation as printed in Cardinal Health's own proxy. As printed: 22,574,349. View filing ↗
  • CVS Health, Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in CVS Health's own proxy. As printed: 21,214,084. View filing ↗
  • Merck & Co., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Merck & Co.'s own proxy. As printed: 20,797,845. View filing ↗
  • Procter & Gamble, Section 10b CEO total. DEF 14A, filed 2026-08-28. CEO total compensation as printed in Procter & Gamble's own proxy. As printed: 18,976,742. View filing ↗
  • Humana, Section 10b CEO total. DEFR 14A, filed 2026-03-06. CEO total compensation as printed in Humana's own proxy. As printed: 18,757,075. View filing ↗
  • Cencora, Section 10b CEO total. DEF 14A, filed 2026-01-22. CEO total compensation as printed in Cencora's own proxy. As printed: 18,256,227. View filing ↗
  • Sysco, Section 10b CEO total. DEF 14A, filed 2026-10-01. CEO total compensation as printed in Sysco's own proxy. As printed: 17,899,369. View filing ↗
  • Viatris, Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Viatris's own proxy. As printed: 15,273,331. View filing ↗
  • Kroger, Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in Kroger's own proxy. As printed: 14,037,608. View filing ↗
  • Costco, Section 10b CEO total. DEF 14A, filed 2025-12-04. CEO total compensation as printed in Costco's own proxy. As printed: 13,932,597. View filing ↗
  • Accendra Health, Inc. (formerly Owens & Minor, Inc.), Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Accendra Health, Inc. (formerly Owens & Minor, Inc.)'s own proxy. As printed: 11,157,809. View filing ↗
  • Target, Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Target's own proxy. As printed: 9,598,071. View filing ↗
  • Section 10a, Cardinal Health reciprocity. DEF 14A. Cardinal Health names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Cencora reciprocity. DEF 14A. Cencora names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Elevance Health reciprocity. DEF 14A. Elevance Health names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, HCA Healthcare reciprocity. DEF 14A. HCA Healthcare names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Humana reciprocity. DEF 14A. Humana names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, The Cigna Group reciprocity. DEF 14A. The Cigna Group names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, UnitedHealth Group reciprocity. DEF 14A. UnitedHealth Group names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Walmart reciprocity. DEF 14A. Walmart names Mckesson Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
Get the full report — $500